Moreover, they demonstrated that TRIM47 could interact with p53 in RCC, so that elevated TRIM47 expression could enhance ubiquitination and degradation of p53, leading to the malignant biological behavior of RCC (Chen et al., 2021). Here, TP53 is linked to renal cell carcinoma.